What You Should Know:
- Augmedics, a provider of augmented reality (AR) surgical navigation, announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process.
- Augmedics’s bid for the digital health assets consists of a cash purchase price of $900,000 and the assumption of certain liabilities, as set forth in the asset purchase agreement. The sale will close pending approval by the Bankruptcy
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Femtech: Juno Diagnostics Shuts Down Commercial Operations
What You Should Know:
Juno Diagnostics, a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions announced it has ceased commercial operations, effective immediately. The company released a statement citing “unforeseen circumstances have led to this difficult decision, and we’re devastated that we can no longer continue our mission-driven work to support expectant mothers like you. As we wind down commercial operations,
Read More
Femtech: HerMD Raises $18M to Transform Women’s Healthcare
What You Should Know:
HerMD, a Cincinnatti, OH-based female-founded physician-led women’s health provider committed to revolutionizing women’s healthcare secures $18M in an oversubscribed Series A-1 round led by existing investor JAZZ, with participation from B-Flexion and Amboy Street Ventures. This new investment brings HerMD’s total funding to nearly $30M.Founded by Chief Medical Officer Dr. Somi Javaid in 2015, HerMD has been revolutionizing the future of women’s healthcare through
Read More
Why Digital Pathology’s Ecosystem Won’t Support AI Startups
Whilst growth in the overall digital pathology AI market is set to scale quickly, cannibalization and consolidation are expected to create headwinds for individual AI vendors. How do investors know where their money is safest?
The recent abundance of digital pathology (DP) media coverage can make it hard to remember that not too long ago, this was a market perpetually ‘lagging’ versus other digital healthcare sectors. And whilst growth has now firmly shifted to its ‘log’ phase, there are
Read More
M&A: New Day Diagnostics to Acquire the Assets of Epigenomics AG
What You Should Know:
New Day Diagnostics LLC announced it has entered into an agreement to acquire the assets of Epigenomics AG, a molecular diagnostics company focused on blood testing for the early detection of cancer.Under the terms of the agreement, New Day Diagnostics would acquire substantially all of Epigenomics AG’s assets and intellectual property. The acquisition would expand New Day Diagnostics' portfolio in the cancer diagnostics space and include proprietary biomarker
Read More
Henry Schein Medical & Medpod Launches Portable Telediagnostic Solution
What You Should Know:
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., and Medpod Inc. launches Medpac – a lightweight, portable telediagnostic solution that allows health care providers to offer comprehensive professional care regardless of location, helping to bridge the gap between remote telemedicine consultations and in-person office visits. Exclusively distributed by Henry Schein Medical, Medpac is suitable for a range of applications, including
Read More
Hippocratic AI Launches Founding Partner Program with Health Systems/Digital Health Companies
What You Should Know:
Hippocratic AI, the first Large Language Model (LLM) designed specifically for healthcare, announced its Founding Partner Program with 10 health systems and digital health companies. Partners will help ensure the safety of Hippocratic AI’s LLM over the course of their five-year partnerships; they will guide the development of the model, participate in data governance and model safety committees, establish use cases, engage their medical professionals in conducting
Read More
FDA Grants Clearance for UltraSight’s AI Cardiac Ultrasound
What You Should Know:
UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it has been granted FDA clearance for its AI-powered ultrasound guidance technology. The UltraSight real-time AI guidance software can assist medical professionals without sonography experience in acquiring cardiac ultrasound images at the point of care in multiple settings, allowing for more widespread detection of heart disease and
Read More
CareCloud, Google Cloud Partner to Bring Generative AI to Ambulatory Practices
What You Should Know:
- Google Cloud and CareCloud, today announced a strategic partnership that will bring the power of generative AI to small and medium-sized healthcare providers.
- Utilizing Google Cloud’s generative AI, CareCloud will transform and enhance the operational efficiency of ambulatory practices in office settings, enabling physicians to make more informed treatment decisions and improving cost transparency between healthcare providers and
Read More
RapidAI Secures $75M for AI-Driven Stroke Care Solutions
What You Should Know:
- RapidAI, a San Mateo, CA-based digital health company developing artificial intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data and technology markets.
- The funding aims to drive platform
Read More
